Adenovirus GMP Production
Adenovirus based gene therapy approaches, including oncolytic adenoviruses, continue to be of high interest to many research groups.
At Vigene, we are passionate about our mission to help support scientists advance their biomedical research and, ultimately, to make gene therapy affordable and accessible to those in need.
As a leader in GMP adenovirus vector production, we have the experience and dedication to quality that you need to scale up your adenovirus gene therapy project into a patient-ready product.
We know that there is no single production strategy that works best for all GMP adenovirus projects, so we offer the flexibility of multiple adenovirus vector production methods and the expert knowledge to help you decide which process will best meet your individual needs.
Click on the Details link button to get more information!
- We perform all the steps to generate the adenovirus seed stock before producing GMP adenovirus.
- We produce GMP adenovirus using the provided virus.